Home
Scholarly Works
THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL...
Conference

THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA

Authors

Rothman K; Huisman MV; Lip G; Diener H-C; Dubner SJ; Ma C-S; Teutsch C; Zint K; Schoof N; Paquette M

Volume

63

Publisher

Elsevier

Publication Date

April 1, 2014

DOI

10.1016/s0735-1097(14)60417-4

Conference proceedings

Journal of the American College of Cardiology

Issue

12

ISSN

0735-1097

Contact the Experts team